"At Genesis Clinical research, we conduct research in a compassionate, professional setting. We strive to increase the quality of life in our patients and to provide the opportunity to access new drugs and medical treatments that may otherwise not be available."

During the past decade, Genesis Clinical Research conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 8 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 6 clinical trials were completed. i.e. 26.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Clinical Research" #1 sponsor was "Pfizer" with 9 trials, followed by "Horizon Therapeutics Ireland DAC" with 2 trials sponsored, "Trevi Therapeutics" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Angion Biomedica Corp" with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Clinical Research" are "Uremic Pruritus" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "COVID-19" (2 trials), "Chronic Kidney Diseases" (2 trials) and "Healthy Volunteers" (2 trials). Many other conditions were trialed in "Genesis Clinical Research" in a lesser frequency.

Most popular intervention types in "Genesis Clinical Research" are "Drug" (27 trials), "Biological" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "PF-07081532" (2 trials), "AMG 451" (1 trials), "ANG-3070" (1 trials) and "Acthar Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Clinical Research" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Genesis Clinical Research". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Genesis Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Clinical Research, 11 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".